FDA Inspection
Organogenesis, Inc.Organogenesis, Inc. – FDA Inspection, Apr 26, 2018
Record Details
This FDA Inspection record concerns Organogenesis, Inc., with an inspection on April 26, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 109fc955-ec96-4867-91a3-0966cbd06354
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1050416
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.290(b)Establishing a system
- 21 CFR 1271.270(a)Accurate, indelible, legible
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Organogenesis, Inc.
15| Date | Classification | Office | Project area |
|---|---|---|---|
| August 29, 2025 | Not classified | New England District Office | |
| December 1, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 8, 2018 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| May 26, 2017 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| September 9, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Organogenesis, Inc.
- FDA Inspection 1273250 - 2025-08-29
- FDA Inspection 1158368 - 2021-12-01
- FDA Inspection 1055007 - 2018-06-08
- FDA Inspection 1014830 - 2017-05-26
- FDA Inspection 942390 - 2015-09-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.